Astal Laboratories adopts FY26 financials at 33rd AGM
- Astal Laboratories Limited held its 33rd AGM on September 29, 2026, via Video Conferencing.
- Shareholders adopted standalone and consolidated audited financial statements for FY26.
- Maggidi Venkatesh was re-appointed as Non-Executive Director after retiring by rotation.
- Thirty-one members participated in the meeting, which concluded at 2:22 pm IST.

*this image is generated using AI for illustrative purposes only.
Astal Laboratories Limited concluded its 33rd Annual General Meeting on September 29, 2026, adopting both standalone and consolidated audited financial statements for the fiscal year ended March 31, 2026. The meeting was conducted entirely through Video Conferencing and Other Audio-Visual Means, ensuring shareholder participation from remote locations.
The proceedings were chaired by Sudheer Karna Kankanala, Whole Time Director, who provided an update on the company's operational and financial activities for FY26. A total of 31 members participated in the virtual meeting, meeting the requisite quorum. The Company Secretary welcomed attendees and confirmed the availability of all statutory registers and reports for electronic inspection during the session.
Key resolutions passed
Shareholders voted on three ordinary business items via the Central Depository Services (India) Limited e-voting portal. The resolutions covered the adoption of financial reports and the re-appointment of a non-executive director retiring by rotation.
| Agenda Item | Resolution Type | Details |
|---|---|---|
| Adoption of Standalone Financials | Ordinary | Audited statements, Board and Auditor reports for FY26 |
| Adoption of Consolidated Financials | Ordinary | Audited statements, Board and Auditor reports for FY26 |
| Director Re-appointment | Ordinary | Maggidi Venkatesh, Non-Executive Director, retires by rotation |
Governance and attendance
The meeting saw the presence of five directors through the virtual platform, including independent directors Hemachakrapani Bangaraiahgari, Julius Paul Reinhard Paschke, and Radhakishore Pandrangi. Mahendra Prakash Khandelwal, a practicing company secretary, served as the scrutinizer for the e-voting process. The Chairman addressed shareholder queries raised by registered speakers and other participants before concluding the session with a vote of thanks.
Consolidated voting results are scheduled to be disseminated to the stock exchange and published on the company website within 48 hours of the meeting's conclusion.
Historical Stock Returns for Astal Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.66% | +0.36% | -10.41% | +2.74% | -16.88% | 0.0% |
How does the adoption of the FY26 financial statements reflect on Astal Laboratories' revenue growth and margin trends compared to the previous fiscal year?
What strategic initiatives or capital expenditure plans were highlighted by the Whole Time Director to drive future operational expansion?
How might the re-appointment of Maggidi Venkatesh influence the company's long-term governance strategy and board dynamics?


































